Strategy Reality
Is the commercial strategy focused, differentiated, and mapped to a real path to revenue?
Commercial GTM Execution Framework
Execution risk becomes manageable when the operating system makes it visible.
A practical advisory framework for pressure-testing strategy, revenue math, pipeline evidence, forecast discipline, operating alignment, and life sciences complexity.
Revenue Math
Does the plan survive deal count, capacity, win rate, cycle length, pipeline coverage, and segment mix?
Pipeline Evidence
Are opportunities backed by buyer proof, decision process, next action, and economic ownership?
Forecast Discipline
Does leadership know what is closing, what is slipping, and what is internal optimism?
Operating System
Are roles, incentives, decision rights, metrics, and accountability reinforcing the same outcome?
Life Sciences Execution Risk
Are regulatory, payer, provider, access, evidence, clinical, launch, and adoption risks built into execution?
Evidence to Execution
Life sciences GTM work has to connect the market path to the evidence path.
Commercial execution becomes stronger when clinical evidence, access requirements, stakeholder proof, launch readiness, and operating accountability are inspected as one system.
Run the execution scorecard
Operating Principle
Pipeline reviews should create decisions, not performance theater.
The framework is designed to move leaders from status reporting to inspection: what is real, what changed, where risk is hiding, and who owns the next action.
In life sciences, that inspection has to include stakeholder evidence, patient access, reimbursement, regulatory timing, clinical adoption, and delivery readiness.
Start with the diagnostic